Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,946 shares of the biopharmaceutical company’s stock after purchasing an additional 1,032 shares during the period. […]

Related Keywords

Metis ,Sakha Yakutiya ,Russia ,Canada ,Jeffreyv Poulton ,William Blair ,Zurcher Kantonalbank Zurich Cantonalbank ,Yvonne Greenstreet ,Sivik Global Healthcare ,Royal Bank ,News Ratings For Alnylam Pharmaceuticals Daily ,Alnylam Pharmaceuticals ,Steel Peak Wealth Management ,Alnylam Pharmaceuticals Price Performance ,Securities Exchange Commission ,Alnylam Pharmaceuticals Inc ,Kokusai Asset Management Co ,Citigroup ,Investment Management ,Metis Global Partners ,Mitsubishi Ufj ,Exchange Commission ,Needham Company ,Sumitomo Mitsui Financial Group ,Quarter For Alnylam Pharmaceuticals ,Nasdaq ,Free Report ,Kantonalbank Zurich Cantonalbank ,Global Partners ,Asset Management ,Peak Wealth Management ,Mitsui Financial Group ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,